Abstract
In the last decade, an increasing number of cardiac conditions have been shown to have a genetic basis. Cardiovascular genetic counseling has emerged as a subspecialty aiming to identify unaffected at-risk individuals. An important sector of this at-risk population also includes expectant mothers, in whom unique clinical challenges may arise. Genetic counselors, especially those in cardiovascular and prenatal settings, have an opportunity to identify and assist women who may benefit from cardiovascular care during pregnancy. This paper provides basic management and genetic evaluation principles for affected women, as well as guidance on identifying those who are at risk. We provide considerations for cardiac surveillance in pregnancy and the post-partum period. Finally, key psychosocial issues that appraise how to best provide support to at risk women as they make informed decisions are discussed. We propose that a team approach including cardiology, maternal fetal medicine, and genetic counseling best serves this patient population. Ongoing questions addressing an evidence based approach to cardiovascular genetic conditions in pregnancy still remain. Thus, well-designed research protocols are essential to mark progress in this area.
Similar content being viewed by others
References
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA). Heart Rhythm, 8, 1308–1339.
Ackerman, M. J., Marcou, C. A., & Tester, D. J. (2013). Personalized medicine: Genetic diagnosis for inherited cardiomyopathies/channelopathies. Reviews Espanolas Cardiology (Engl Ed), 66, 298–307.
ACOG Practice Bulletin No. 88. (2007). Invasive prenatal testing for aneuploidy. American College of Obstetricians and Gynecologists. Obstetrics and Gynecology, 110, 1459–1467.
Allison, S. J., Stafford, J., & Anumba, D. O. (2011). The effect of stress and anxiety associated with maternal prenatal diagnosis on feto-maternal attachment. BMC Womens Health, 11, 33.
Bauce, B., Daliento, L., Frigo, G., Russo, G., & Nava, A. (2006). Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127, 186–189.
Bedard, E., Dimopoulos, K., & Gatzoulis, M. A. (2009). Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? European Heart Journal, 30, 256–265.
Beighton, P., De Paepe, A., Steinmann, B., Tsipouras, P., & Wenstrup, R. J. (1998). Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos support group (UK). American Journal of Medical Genetics, 77, 31–37.
Bendszus, M., Koltzenburg, M., Bartsch, A. J., Goldbrunner, R., Gunthner-Lengsfeld, T., Weilbach, F. X., et al. (2004). Heparin and air filters reduce embolic events caused by intra-arterial cerebral angiography: A prospective, randomized trial. Circulation, 110, 2210–2215.
Bergeron, M. E., Child, T., & Fatum, M. (2014). In vitro maturation and surrogacy in patients with vascular-type Ehlers-Danlos syndrome--a safe assisted reproductive technology approach. Human Fertility (Cambridge, England), 17, 141–144.
Bieskeker, B. B. (2001). Goals of genetic counseling. Clinical Genetics, 60, 323–330.
Blomstrom-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., et al. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. Journal of the American College of Cardiology, 42, 1493–1531.
Bons, L. R., & Roos-Hesselink, J. W. (2016). Aortic disease and pregnancy. Current Opinion in Cardiology, 31, 611.
Briggs, G.G. (2011). Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk (9th ed. 2011 ed.). Philadelphia: Wolter Kluwer Health/Lippincott Williams & Wilkins.
Burkett, E. L., & Hershberger, R. E. (2005). Clinical and genetic issues in familial dilated cardiomyopathy. Journal of the American College of Cardiology, 45, 969–981.
Chaix, M. A., Andelfinger, G., & Khairy, P. (2016). Genetic testing in congenital heart disease: A clinical approach. World Journal of Cardiology, 8, 180–191.
Chandra, N. C., Gates, E. A., & Thamer, M. (1991). Conservative treatment of paroxysmal ventricular tachycardia during pregnancy. Clinical Cardiology, 14, 347–350.
Cowan, J. R., & Ware, S. M. (2015). Genetics and genetic testing in congenital heart disease. Clinics in Perinatology, 42, 373–393.
Cox, S., O'Donoghue, A. C., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart, 78, 182–187.
Cuneo, B. F., Etheridge, S. P., Horigome, H., Sallee, D., Moon-Grady, A., Weng, H. Y., et al. (2013). Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: Risk stratification of perinatal long-QT syndrome. Circulation. Arrhythmia and Electrophysiology, 6, 946–951.
Danielsson, B. R., Skold, A. C., & Azarbayjani, F. (2001). Class III antiarrhythmics and phenytoin: Teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage. Current Pharmaceutical Design, 7, 787–802.
Dolgin, M. (1994). The Criteria Committee of the New York Heart Association. In 9th ed (Ed.), Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels (pp. 253–256). Boston: Little, Brown & Co.
Drenthen, W., Boersma, E., Balci, A., Moons, P., Roos-Hesselink, J. W., Mulder, B. J., et al. (2010). Predictors of pregnancy complications in women with congenital heart disease. European Heart Journal, 31, 2124–2132.
Ekholm, E. M., Piha, S. J., Erkkola, R. U., & Antila, K. J. (1994). Autonomic cardiovascular reflexes in pregnancy. A longitudinal study. Clinical Autonomous Research, 4, 161–165.
El-Hamamsy, I., & Yacoub, M. H. (2009). Cellular and molecular mechanisms of thoracic aortic aneurysms. Nature Reviews. Cardiology, 6, 771–786.
Elkayam, U., & Bitar, F. (2005a). Valvular heart disease and pregnancy part I: Native valves. Journal of the American College of Cardiology, 46, 223–230.
Elkayam, U., & Bitar, F. (2005b). Valvular heart disease and pregnancy: Part II: Prosthetic valves. Journal of the American College of Cardiology, 46, 403–410.
Elkayam, U., Tummala, P. P., Rao, K., Akhter, M. W., Karaalp, I. S., Wani, O. R., et al. (2001). Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. The New England Journal of Medicine, 344, 1567–1571.
Elkayam, U., Goland, S., Pieper, P. G., & Silverside, C. K. (2016). High-risk cardiac disease in pregnancy: Part I. Journal of the American College of Cardiology, 68, 396–410.
Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., et al. (2008). Classification of the cardiomyopathies: A position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. European Heart Journal, 29, 270–276.
Ferrero, S., Colombo, B. M., & Ragni, N. (2004). Maternal arrhythmias during pregnancy. Archives of Gynecology and Obstetrics, 269, 244–253.
Fett, J. D. (2011). Validation of a self-test for early diagnosis of heart failure in peripartum cardiomyopathy. Critical Pathways in Cardiology, 10, 44–45.
Fett, J. D., Shah, T. P., & McNamara, D. M. (2015). Why do some recovered peripartum cardiomyopathy mothers experience heart failure with a subsequent pregnancy? Current Treatment Options in Cardiovascular Medicine, 17, 354.
GeneTests Medical Genetics Information Resource (database online). (1993). Copyright. Seattle: University of Washington Available at http://www.genetests.org Accessed 11 Jan 2016.
Gill, H. K., Splitt, M., Sharland, G. K., & Simpson, J. M. (2003). Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. Journal of the American College of Cardiology, 42, 923–929.
Goel, K., Tweet, M., & Olson, T. M. (2015). Familial spontaneous coronary artery dissection: Evidence for genetic susceptiblity. JAMA Internal Medicine, 175, 821–826.
Gollob, M. H., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., et al. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian cardiovascular society/Canadian Heart Rhythm Society joint position paper. The Canadian Journal of Cardiology, 27, 232–245.
Gowda, R. M., Khan, I. A., Mehta, N. J., Vasavada, B. C., & Sacchi, T. J. (2003). Cardiac arrhythmias in pregnancy: Clinical and therapeutic considerations. International Journal of Cardiology, 88, 129–133.
Grobstein, R. (1979). Amniocentesis counseling. In genetic counseling psychological dimensions. New York: Academic Press.
Groeneweg, J. A., Bhonsale, A., James, C. A., te Riele, A. S., Dooijes, D., Tichnell, C., et al. (2015). Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circulation. Cardiovascular Genetics, 8(3), 437–446. doi:10.1161/CIRCGENETICS.114.001003.
Hameed, A., Karaalp, I. S., Tummala, P. P., Wani, O. R., Canetti, M., Akhter, M. W., et al. (2001). The effect of valvular heart disease on maternal and fetal outcome of pregnancy. Journal of the American College of Cardiology, 37, 893–899.
Hassan, N., Patenaude, V., Oddy, L., & Abenhaim, H. A. (2015). Pregnancy outcomes in Marfan syndrome: A retrospective cohort study. American Journal of Perinatology, 30, 123–130.
Helbig, K. L., Bernhardt, B. A., Conway, L. J., Valverde, K. D., Helbig, I., & Sperling, M. R. (2010). Genetic risk perception and reproductive decision making among people with epilepsy. Epilepsia, 51, 1874–1877.
Hershberger, R. E., Hedges, D. J., & Morales, A. (2013). Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nature Reviews. Cardiology, 10, 531–547.
Hess, R. F., & Weinland, J. A. (2012). The life-changing impact of peripartum cardiomyopathy: An analysis of online postings. MCN: American Journal of Maternal Child Nursing, 37, 241–246.
Hess, R. F., Weinland, J. A., & Beebe, K. (2010). "I am not alone": A survey of women with peripartum cardiomyopathy and their participation in an online support group. Computers, Informatics, Nursing, 28, 215–221.
Hidayatallah, N., Silverstein, L. B., Stolerman, M., McDonald, T., Walsh, C. A., Paljevic, E., et al. (2014). Psychological stress associated with cardiogenetic conditions. Personalized Medicine, 11, 631–640.
Higgins, R. O., Murphy, B., Nicholas, A., Worcester, M., & Lindner, H. (2007). Emotional and adjustment issues faced by cardiac patients seen in clinical practice: A qualitative survey of experienced clinicians. Journal of Cardiopulmonary Rehabilitation and Prevention, 27, 291–297.
Immer, F. F., Bansi, A. G., Immer-Bansi, A. S., McDougall, J., Zehr, K. J., Schaff, H. V., et al. (2003). Aortic dissection in pregnancy: Analysis of risk factors and outcome. The Annals of Thoracic Surgery, 76, 309–314.
Ingles, J., Lind, J., Phongsavan, P., & Semsarian, C. (2008). Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine, 10, 117–120.
Jacobs, K., Giacobbe, L., Aguilera, M., Ramin, K., & Sivanandam, S. (2014). A case of fetal diagnosis of noncompaction cardiomyopathy and coarctation of the aorta. AJP Report, 4, 45–48.
Joglar, J. A., & Page, R. L. (2014). Management of arrhythmia syndromes during pregnancy. Current Opinion in Cardiology, 29, 36–44.
Judge, D. P., & Dietz, H. C. (2005). Marfan's syndrome. Lancet, 366, 1965–1976.
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley Jr., W. G., Froelich, J. W., et al. (2013). ACR guidance document on MR safe practices: 2013. Journal of Magnetic Resonance Imaging, 37, 501–530.
Kerstjens-Frederikse, W. S., Du Marchie Sarvaas, G. J., Ruiter, J. S., Van Den Akker, P. C., Temmerman, A. M., Van Melle, J. P., et al. (2011). Left ventricular outflow tract obstruction: Should cardiac screening be offered to first-degree relatives? Heart, 97, 1228–1232.
Khoo, B. (2015). Genetic therapies to lower cholesterol. Vascular Pharmacology, 64, 11–15.
Klitzman, R., Thorne, D., Williamson, J., Chung, W., & Marder, K. (2007). Decision-making about reproductive choices among individuals at-risk for Huntington's disease. Journal of Genetic Counseling, 16, 347–362.
Kuliev, A., Pomerantseva, E., Polling, D., Verlinsky, O., & Rechitsky, S. (2012). PGD for inherited cardiac diseases. Reproductive Biomedicine Online, 24, 443–453.
Lima, F. V., Parikh, P. B., Zhu, J., Yang, J., & Stergiopoulos, K. (2015). Association of cardiomyopathy with adverse cardiac events in pregnant women at the time of delivery. JACC Heart Fail, 3, 257–266.
Lind, J., & Wallenburg, H. C. (2001). The Marfan syndrome and pregnancy: A retrospective study in a Dutch population. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 98, 28–35.
Loeys, B. L., Dietz, H. C., Braverman, A. C., Callewaert, B. L., De Backer, J., Devereux, R. B., et al. (2010). The revised Ghent nosology for the Marfan syndrome. Journal of Medical Genetics, 47, 476–485.
Lu, C. W., Shih, J. C., Chen, S. Y., Chiu, H. H., Wang, J. K., Chen, C. A., et al. (2015). Comparison of 3 risk estimation methods for predicting cardiac outcomes in pregnant women with congenital heart disease. Circulation Journal, 79, 1609–1617.
Malfait, F., Wenstrup, R., De Paepe, A. (1997-2013). Ehlers-Danlos Syndrome, Classic Type. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online). Retrieved 23 Apr 2016 http://www.genetests.org.
Malfait, F., Wenstrup, R. J., & De Paepe, A. (2010). Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genetics in Medicine, 12, 597–605.
Meijboom, L. J., Vos, F. E., Timmermans, J., Boers, G. H., Zwinderman, A. H., & Mulder, B. J. (2005). Pregnancy and aortic root growth in the Marfan syndrome: A prospective study. European Heart Journal, 26, 914–920.
Miller, T. E., Estrella, E., Myerburg, R. J., Garcia de Viera, J., Moreno, N., Rusconi, P., et al. (2004). Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome. Circulation, 109(24), 3029–3034. doi:10.1161/01.CIR.0000130666.81539.9E.
Morales, A., Cowan, J., Dagua, J., & Hershberger, R. E. (2008). Family history: An essential tool for cardiovascular genetic medicine. Congestive Heart Failure, 14(1), 37–45.
Morales, A., Painter, T., Li, R., Siegfried, J. D., Li, D., Norton, N., et al. (2010). Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation, 121, 2176–2182.
Morgan, J. F., O'Donoghue, A. C., McKenna, W. J., & Schmidt, M. M. (2008). Psychiatric disorders in hypertrophic cardiomyopathy. General Hospital Psychiatry, 30, 49–54.
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., et al. (2015). Heart disease and stroke statistics--2015 update: A report from the American Heart Association. Circulation, 131, e29–322.
Murray, M. L., Pepin, M., Peterson, S., & Byers, P. H. (2014). Pregnancy-related deaths and complications in women with vascular Ehlers-Danlos syndrome. Genetics in Medicine, 16, 874–880.
Nakagawa, M., Katou, S., Ichinose, M., Nobe, S., Yonemochi, H., Miyakawa, I., et al. (2004). Characteristics of new-onset ventricular arrhythmias in pregnancy. Journal of Electrocardiology, 37, 47–53.
Napolitano, C., Priori, S.G., Bloise, R. (2004-2016). Catecholaminergic Polymorphic Ventricular Tachycardia. In GeneReviews at GeneTests Medical Genetics Information Resource (database online). Retrieved 20 Oct 2016 http://www.genetests.org.
Naqvi, T. Z. (2014). Challenges in cardiology research in pregnancy. Future Cardiology, 10, 759–768.
National Institutes of Health Genetic Testing Registry (database online). (2013). Copyright, National Center for biotechnology information. Bethesda, Maryland: U.S. National Library of Medicine Available at http://www.ncbi.nlm.nih.gov/gtr/ Accessed 11 Jan 2016.
Nizamuddin, S. L., Broderick, D. K., Minehart, R. D., & Kamdar, B. B. (2015). Spontaneous coronary artery dissection in a parturient with nail-patella syndrome. International Journal of Obstetric Anesthesia, 24, 69–73.
Omnes, S., Jondeau, G., Detaint, D., Dumont, A., Yazbeck, C., Guglielminotti, J., et al. (2013). Pregnancy outcomes among women with Marfan syndrome. International Journal of Gynaecology and Obstetrics, 122, 219–223.
Palmer, D. G. (2006). Peripartum cardiomyopathy. The Journal of Perinatal & Neonatal Nursing, 20, 324–332.
Palmquist, M., Pappas, J. G., Petrikovsky, B., Blakemore, K., & Roshan, D. (2009). Successful pregnancy outcome in Ehlers-Danlos syndrome, vascular type. The Journal of Maternal-Fetal & Neonatal Medicine, 22, 924–927.
Panayotova, R., Macnab, A., & Waterworth, P. D. (2013). A pilot project of familial screening in patients with bicuspid aortic valve disease. The Journal of Heart Valve Disease, 22, 150–155.
Pedra, S. R., Smallhorn, J. F., Ryan, G., Chitayat, D., Taylor, G. P., Khan, R., et al. (2002). Fetal cardiomyopathies: Pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation, 106, 585–591.
Pepin, M., Murray, M.L., Byers, B.H. (1997-2013). Vascular Ehlers Danlos. In GeneReviews at GeneTests Medical Genetics Information Resource (database online). Retrieved 23 Apr 2016 http://www.genetests.org.
Pepin, M. G., Schwarze, U., Rice, K. M., Liu, M., Leistritz, D., & Byers, P. H. (2014). Survival is affected by mutation type and molecular mechanism in vascular Ehlers-Danlos syndrome (EDS type IV). Genetics in Medicine, 16, 881–888.
Pierpont, M. E., Basson, C. T., Benson, D. W., Gelb, B. D., Giglia, T. M., Goldmuntz, E., McGee, G., Sable, C. A., Srivastava, D., & Webb, C. L. (2007). Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American Heart Association congenital cardiac defects committee, council on cardiovascular disease in the young: Endorsed by the American Academy of Pediatrics. Circulation, 115, 3015–3038.
Pijuan-Domenech, A., Galian, L., Goya, M., Casellas, M., Merced, C., Ferreira-Gonzalez, I., et al. (2015). Cardiac complications during pregnancy are better predicted with the modified WHO risk score. International Journal of Cardiology, 195, 149–154.
Poole, N. A., & Morgan, J. F. (2006). Validity and reliability of the hospital anxiety and depression scale in a hypertrophic cardiomyopathy clinic: The HADS in a cardiomyopathy population. General Hospital Psychiatry, 28, 55–58.
Postma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J. M., Vaksmann, G., et al. (2005). Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Journal of Medical Genetics, 42(11), 863–870. doi:10.1136/jmg.2004.028993.
Priori, S. G., Wilde, A. A., Horie, M., Cho, Y., Behr, E. R., Berul, C., et al. (2013). HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in may 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm, 10, 1932–1963.
Rashba, E. J., Zareba, W., Moss, A. J., Hall, W. J., Robinson, J., Locati, E. H., et al. (1998). Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation, 97, 451–456.
Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J. M., et al. (2011). ESC guidelines on the management of cardiovascular diseases during pregnancy: The task force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology (ESC). European Heart Journal, 32, 3147–3197.
Regitz-Zagrosek, V., Gohlke-Barwolf, C., Iung, B., & Pieper, P. G. (2014). Management of cardiovascular diseases during pregnancy. Current Problems in Cardiology, 39, 85–151.
Reprotox, Reproductive Toxicology Center. (2016). Retrieved Apr 2015 www.reprotox.org.
Rychik, J., Donaghue, D. D., Levy, S., Fajardo, C., Combs, J., Zhang, X., et al. (2013). Maternal psychological stress after prenatal diagnosis of congenital heart disease. The Journal of Pediatrics, 162(302–307), e301.
Seth, R., Moss, A. J., McNitt, S., Zareba, W., Andrews, M. L., Qi, M., et al. (2007). Long QT syndrome and pregnancy. Journal of the American College of Cardiology, 49, 1092–1098.
Siu, S. C., Sermer, M., Colman, J. M., Alvarez, A. N., Mercier, L. A., Morton, B. C., et al. (2001). Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation, 104, 515–521.
Sliwa, K., van Hagen, I. M., Budts, W., Swan, L., Sinagra, G., Caruana, M., et al. (2016). Pulmonary hypertension and pregnancy outcomes: Data from the registry of pregnancy and cardiac disease (ROPAC) of the European Society of Cardiology. European Journal of Heart Failure, 18, 1119–1128.
Tanaka, K., Tanaka, H., Kamiya, C., Katsuragi, S., Sawada, M., Tsuritani, M., et al. (2016). Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circulation Journal, 80, 2221–2226.
Tarani, L., Lampariello, S., Raguso, G., Colloridi, F., Pucarelli, I., Pasquino, A. M., et al. (1998). Pregnancy in patients with Turner's syndrome: Six new cases and review of literature. Gynecological Endocrinology, 12, 83–87.
Teekakirikul, P., Kelly, M. A., Rehm, H. L., Lakdawala, N. K., & Funke, B. H. (2013). Inherited cardiomyopathies: Molecular genetics and clinical genetic testing in the postgenomic era. The Journal of Molecular Diagnostics, 15, 158–170.
Tester, D. J., & Ackerman, M. J. (2005). Genetic testing for cardiac channelopathies: Ten questions regarding clinical considerations for heart rhythm allied professionals. Heart Rhythm, 2(6), 675–677. doi:10.1016/j.hrthm.2004.09.024.
Tsiaras, S., & Poppas, A. (2009). Mitral valve disease in pregnancy: Outcomes and management. Obstetrics Medicine, 2, 6–10.
Uebing, A., Steer, P. J., Yentis, S. M., & Gatzoulis, M. A. (2006). Pregnancy and congenital heart disease. BMJ, 332, 401–406.
van Spaendonck-Zwarts, K. Y., Posafalvi, A., van den Berg, M. P., Hilfiker-Kleiner, D., Bollen, I. A., Sliwa, K., et al. (2014). Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. European Heart Journal, 35, 2165–2173.
Van Tintelen, J. P., Pieper, P. G., Van Spaendonck-Zwarts, K. Y., & Van Den Berg, M. P. (2014). Pregnancy, cardiomyopathies, and genetics. Cardiovascular Research, 101, 571–578.
Vohnout, B., Gabcova, D., Huckova, M., Klimes, I., Gasperikova, D., & Raslova, K. (2016). Genetic testing of familial hypercholesterolemia in a real clinical setting. Wien Klin Wochenschr. Epub. doi:10.1007/s00508-016-1053-2.
Wang, M. (2009). Peripartum cardiomyopathy: Case reports. The Permanente Journal, 13, 42–45.
Wanga, S., Silversides, C., Dore, A., de Waard, V., & Mulder, B. (2016). Pregnancy and thoracic aortic disease: Managing the risks. The Canadian Journal of Cardiology, 32, 78–85.
Webb, G., & Gatzoulis, M. A. (2006). Atrial septal defects in the adult: Recent progress and overview. Circulation, 114, 1645–1653.
Webb, G., & Williams, R. (2001). 32nd Bethesda conference: ‘care of the adult with congenital heart disease’. Journal of the American College of Cardiology, 37, 1162–1198.
Weber, R., Kantor, P., Chitayat, D., Friedberg, M. K., Golding, F., Mertens, L., et al. (2014). Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life. JACC Heart Fail, 2(4), 403–411. doi:10.1016/j.jchf.2014.02.010.
Weil, J. (2000). Psychosocial genetic counseling (pp. 155). New York: Oxford University Press.
Wilkins, R. G., & Unverdorben, M. (2012). Accidental intravenous infusion of air: A concise review. Journal of Infusion Nursing, 35, 404–408.
Yuan, S. M. (2013). Postpartum aortic dissection. Taiwanese Journal of Obstetrics & Gynecology, 52, 318–322.
Zlotogora, J. (1998). Germ line mosaicism. Human Genetics, 102, 381–386.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ana Morales, MS, CGC - none.
Dawn C. Allain, MS, CGC - none.
Patricia Arscott, MS, CGC - none.
Emily James MS, CGC - none.
Gretchen MacCarrick, MS, CGC - none.
Brittney Murray, MS, CGC - none.
Crystal Tichnell, MGC - none.
Amy R. Shikany, MS, CGC – Consultant, Omicia, Inc.
Sara Spencer, MS, CGC - none.
Sara M. Fitzgerald-Butt, MS, CGC - Cardio Advisory Board, Invitae.
Jessica D. Kushner, MS, CGC - none.
Christi Munn, MS, CGC - Employed by Bioreference Laboratories/GeneDx.
Emily Smith, MS, CGC - none.
Katherine G. Spoonamore, MS, CGC - Cardio Advisory Board, Invitae.
Harikrishna S. Tandri, MD - none.
W. Aaron Kay, MD - none.
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s10897-017-0101-z.
Rights and permissions
About this article
Cite this article
Morales, A., Allain, D.C., Arscott, P. et al. At the Heart of the Pregnancy: What Prenatal and Cardiovascular Genetic Counselors Need to Know about Maternal Heart Disease. J Genet Counsel 26, 669–688 (2017). https://doi.org/10.1007/s10897-017-0081-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-017-0081-z